Cardiac arrhythmias in patients with SARS-CoV‑2 infection and effects of the lockdown on invasive rhythmological therapyOriginal Contributions Published on 2020-12-232022-10-31 Journal: Herzschrittmachertherapie & Elektrophysiologie [Category] COVID-19, MERS, SARS, [키워드] Act acute respiratory syndrome arrhythmia bradycardia cardiac Cardiac arrhythmia Cardiology Care Catheter ablation clinical symptom consequence coronavirus disease COVID-19 Effect Electrophysiology Elektrophysiologie Germany Herzschrittmacher hospital incidence increase in Intervention invasive Katheterablation lockdown majority medical intervention objective outbreak pacemaker pandemic Pandemie Patient Patient care patients performed protection recorded reduce reduced reduction in reported required Result risk of infection SARS-CoV-2 SARS-CoV‑2 infection Society Tachycardia the patient therapy treated Treatment Volume [DOI] 10.1007/s00399-020-00734-3 PMC 바로가기 [Article Type] Original Contributions
Cardiovascular complications and its impact on outcomes in COVID-19Observational Study Published on 2020-11-012022-10-05 Journal: Indian heart journal [Category] SARS, 바이오마커, 임상, [키워드] Acute cardiac injury Acute coronary syndrome age baseline Biomarker bradycardia cardiac cardiogenic Cardiogenic shock cardiovascular cardiovascular system co-morbidities collected Complication coronary syndrome Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients CV complication CV complications diabete ECG electrocardiogram evaluate heart heart failure Hospitalization independent predictor indication inotropic agent Laboratory Limited Logistic regression analysis lymphopenia majority male morbidity and mortality Mortality multivariate myocarditis outcome patients prevalent QT-interval QTc QTC prolongation Shock single center subjects symptomatic Tachycardia Treatment was done widespread worse prognosis [DOI] 10.1016/j.ihj.2020.10.005 PMC 바로가기 [Article Type] Observational Study
Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, JapanExpedited Published on 2020-10-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, SARS, [키워드] Affect bradycardia cardiovascular system characteristic clinician coronavirus disease Coronaviruses COVID-19 diagnose disease help Japan Mild-to-moderate mild-to-moderate coronavirus disease Patient PCR-confirmed relative relative bradycardia reported respiratory infections SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses [DOI] 10.3201/eid2610.202648 PMC 바로가기 [Article Type] Expedited
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trialStudy Protocol Published on 2020-07-312022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] 24 hour addition Administered adverse event all subject allocation sequence Analysis antiviral activity Antiviral effect Arm arrhythmia Asymptomatic bradycardia can be used carried Cell Chronic kidney disease clinical Cluster Clusters Comorbidity Compliance conducted congestive heart failure Contact contraindication Coronaviruses covariates COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 patient COVID-19 patients COVID-19 symptom Data monitoring committee database deficiency defined Department diabete diagnostic dialysis disease dissemination diuretics dose drug Drug-drug interactions during treatment early treatment Efficacy element eligible endosomal pH ENhance enrolled Epidemic Epidemiology equation EudraCT evaluate Evidence expected Factor female Final G6PD Generalized generate Glucose-6-phosphate glycosylation group Healthcare professional Hydroxychloroquine hydroxychloroquine/chloroquine identify in vitro in vivo inclusion criteria independent index index case index cases Infection interim analysis involved IRCCS ischemic heart disease Italian region Italy Loading dose male malignancy medication mental illness mild symptoms neurological number objective observation open label oropharyngeal swab outcome parallel group participant Patient patients with COVID-19 Paucisymptomatic performed positive PCR test Prevent prevention prevention of COVID-19 Prophylaxis proportion Proteins protocol protocol amendment Public QT prolongation randomization Randomized Randomized controlled clinical trial Randomized controlled trial reached receive recorded recruited reduced reduction in Registered reported required risk Sample size SARS-CoV-2 shown Standard status stratified Studio Study protocol subject subjects Support Swab Symptom symptomatic syndrome Tablet therapeutic approaches therapy Toxicity treat treated Treatment Trial trial protocol ventricular viral surface virus virus infection website with COVID-19 [DOI] 10.1186/s13063-020-04527-4 PMC 바로가기 [Article Type] Study Protocol
Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series ReviewCardiology Published on 2020-07-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory distress acute respiratory syndrome adverse effect antimalarial ARDS Asymptomatic benefit bradycardia cardiovascular caused Community coronavirus coronavirus disease COVID 19 COVID-19 Efficacy Evidence HCQ heterogeneous nature Hydroxychloroquine lack medication pandemic Patient prolonged qt Randomized controlled trials review risk-benefit SARS-CoV-2 Sery Side effect Symptom syndrome the disease therapeutic therapeutic effect virulence while [DOI] 10.7759/cureus.9151 PMC 바로가기 [Article Type] Cardiology
Cardiovascular manifestations in severe and critical patients with COVID ‐19Clinical Investigations Published on 2020-06-202022-10-31 Journal: Clinical Cardiology [Category] COVID-19, [키워드] acute respiratory syndrome Admission analyzed arrythmia Atrial fibrillation blood pressure bradycardia cardiac function cardiac injury cardiac marker cardiovascular Cardiovascular manifestations cardiovascular system Clinical outcome Corona coronavirus COVID COVID‐19 COVID‐19 infection COVID‐19 patient COVID‐19 Critical Critical case critical cases critical status D‐dimer diabetes diagnosed enrolled Factor FIVE heart failure Hospitalization Hypotension independent risk factor Infection Inflammatory Intervention less male manifestation monitoring myocardial injury occurred Occurrence organ Patient patients Pneumonia Result SARS‐CoV‐2 Seven Severe case Severe patient severity significantly higher Sinus tachycardia suffered systemically Tachycardia TnI Treatment troponin ventricular virulent vital sign [DOI] 10.1002/clc.23384 PMC 바로가기 [Article Type] Clinical Investigations
Bradycardia in Patients With COVID-19: A Calm Before the Storm?Cardiology Published on 2020-06-132022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Admission arrhythmia association bradycardia cardiac cardiovascular case sery Comorbidity contributing to Corona Virus Disease coronavirus coronavirus disease correlation COVID-19 Cytokine release syndrome (CRS) Cytokine storm demographic described dexmedetomidine ECG Effects electrocardiogram EpiC Fahrenheit females FIVE Health heart rate ICU Infection Inflammatory knowledge Laboratory laboratory-confirmed lowest maintain male manifestation maximum body temperature mean arterial pressure medication multifactorial network nine pacemaker cells Patient pro-inflammatory cytokine Prolonged propofol QTc interval ranged receiving reported required retrospective SARS-CoV-2 sars-cov-2 (severe acute respiratory syndrome coronavirus -2) severe hypoxia Surveillance Transient Treatment triggers Two patient university Vasopressor [DOI] 10.7759/cureus.8599 PMC 바로가기 [Article Type] Cardiology
Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumoniaResearch Letter Published on 2020-05-262022-11-01 Journal: Critical Care [Category] Coronavirus, MERS, SARS, [키워드] ACE2 Analysis bradycardia clinical clinical manifestation COVID-19 Patient Severe COVID-19 pneumonia severe pneumonia sinus bradycardia [DOI] 10.1186/s13054-020-02933-3 PMC 바로가기 [Article Type] Research Letter
Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019Emergency Medicine Published on 2020-04-242022-10-31 Journal: Cureus [Category] COVID-19, [키워드] av nodal blockers blockade bradycardia brash syndrome Coronavirus disease 2019 COVID-19 end-organ damage failure global pandemic hyperkalemia novel coronavirus disease predominant presentation renal renal failure Respiratory failure sars-cov-2 (severe acute respiratory syndrome coronavirus -2) Shock syndrome triggered while [DOI] 10.7759/cureus.7816 PMC 바로가기 [Article Type] Emergency Medicine
Herpes Zoster-induced Progressive Heart Block: A Case Reportarticle Published on 2018-12-032024-09-02 Journal: Cureus [Category] 대상포진, [키워드] bradycardia Cardiology Case report EKG heart block Varicella zoster virus [DOI] 10.7759/cureus.3674 PMC 바로가기 [Article Type] article